Search research articles
Contact Us
Filters
Showing results (61-70 of 96) with videos related to
Page
of 10
Sort By:
British Journal of Pharmacology
|
January 30, 2002
Histamine H3-receptor-mediated [35S]GTP gamma[S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors
A Rouleau, X Ligneau, J Tardivel-Lacombe, et al.
Agents and Actions. Supplements
|
January 1, 1991
The histamine H3-receptor: pharmacology, roles and clinical implications studied with agonists
J M Arrang, M Garbarg, J C Schwartz, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 31, 2000
Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H3-receptor antagonists
H Stark, X Ligneau, B Sadek, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 11, 2001
Different antagonist binding properties of human and rat histamine H3 receptors
H Stark, W Sippl, X Ligneau, et al.
Progress in Medicinal Chemistry
|
January 5, 2002
The histamine H3 receptor and its ligands
H Stark, J M Arrang, X Ligneau, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 15, 1993
Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation
M Ruat, E Traiffort, R Leurs, et al.
Journal of Medicinal Chemistry
|
March 1, 1996
Novel carbamates as potent histamine H3 receptor antagonists with high in vitro and oral in vivo activity
H Stark, K Purand, X Ligneau, et al.
Brain Research
|
July 23, 1990
Involvement of histaminergic neurons in arousal mechanisms demonstrated with H3-receptor ligands in the cat
J S Lin, K Sakai, G Vanni-Mercier, et al.
Archiv Der Pharmazie
|
August 1, 1996
Novel histamine H3-receptor antagonists with benzyl ether structure or related moieties: synthesis and structure-activity relationships
A Hüls, K Purand, H Stark, et al.
Archiv Der Pharmazie
|
August 26, 1998
Development of FUB 181, a selective histamine H3-receptor antagonist of high oral in vivo potency with 4-(omega-(arylalkyloxy)alkyl)-1H-imidazole structure
H Stark, A Hüls, X Ligneau, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 96) with videos related to
Sort By:
Page
of 10
British Journal of Pharmacology
|
January 30, 2002
Histamine H3-receptor-mediated [35S]GTP gamma[S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors
A Rouleau, X Ligneau, J Tardivel-Lacombe, et al.
Agents and Actions. Supplements
|
January 1, 1991
The histamine H3-receptor: pharmacology, roles and clinical implications studied with agonists
J M Arrang, M Garbarg, J C Schwartz, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 31, 2000
Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H3-receptor antagonists
H Stark, X Ligneau, B Sadek, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 11, 2001
Different antagonist binding properties of human and rat histamine H3 receptors
H Stark, W Sippl, X Ligneau, et al.
Progress in Medicinal Chemistry
|
January 5, 2002
The histamine H3 receptor and its ligands
H Stark, J M Arrang, X Ligneau, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 15, 1993
Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation
M Ruat, E Traiffort, R Leurs, et al.
Journal of Medicinal Chemistry
|
March 1, 1996
Novel carbamates as potent histamine H3 receptor antagonists with high in vitro and oral in vivo activity
H Stark, K Purand, X Ligneau, et al.
Brain Research
|
July 23, 1990
Involvement of histaminergic neurons in arousal mechanisms demonstrated with H3-receptor ligands in the cat
J S Lin, K Sakai, G Vanni-Mercier, et al.
Archiv Der Pharmazie
|
August 1, 1996
Novel histamine H3-receptor antagonists with benzyl ether structure or related moieties: synthesis and structure-activity relationships
A Hüls, K Purand, H Stark, et al.
Archiv Der Pharmazie
|
August 26, 1998
Development of FUB 181, a selective histamine H3-receptor antagonist of high oral in vivo potency with 4-(omega-(arylalkyloxy)alkyl)-1H-imidazole structure
H Stark, A Hüls, X Ligneau, et al.
Page
of 10